Cargando…

Sympathetic signaling facilitates progression of neuroendocrine prostate cancer

The progression of prostate cancer (PC) into neuroendocrine prostate cancer (NEPC) is a major challenge in treating PC. In NEPC, the PC cells undergo neuroendocrine differentiation (NED); however, the exact molecular mechanism that triggers NED is unknown. Peripheral nerves are recently shown to pro...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dwivedi, Shubham, Bautista, Maricris, Shrestha, Sanskriti, Elhasasna, Hussain, Chaphekar, Tanaya, Vizeacoumar, Frederick S., Krishnan, Anand
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8608828/ https://www.ncbi.nlm.nih.gov/pubmed/34811362 http://dx.doi.org/10.1038/s41420-021-00752-1

Ejemplares similares

A Drug Repurposing Screen Identifies Fludarabine Phosphate as a Potential Therapeutic Agent for N-MYC Overexpressing Neuroendocrine Prostate Cancers
por: Elhasasna, Hussain, et al.
Publicado: (2022)

The Autonomic Regulation of Tumor Growth and the Missing Links
por: Bautista, Maricris, et al.
Publicado: (2020)

Self-renewal of peripheral nerve resident macrophage: does it represent a unique activation status?
por: Bautista, Maricris, et al.
Publicado: (2021)

Sympathetic nervous signaling dictates prostate cancer progression
por: Sigorski, D., et al.
Publicado: (2022)

Alternative RNA splicing of the MEAF6 gene facilitates neuroendocrine prostate cancer progression
por: Lee, Ahn R., et al.
Publicado: (2017)

Neurokinin-1 receptor drives PKCɑ-AURKA/N-Myc signaling to facilitate the neuroendocrine progression of prostate cancer
por: Zhang, Xiao-Wei, et al.
Publicado: (2023)

Loss of EHF facilitates the development of treatment-induced neuroendocrine prostate cancer
por: Long, Zhi, et al.
Publicado: (2021)

Loss of the Sympathetic Signal Produces Sterile Inflammation of the Prostate
por: Hu, Hao, et al.
Publicado: (2022)

Comparative Proteomics Analysis of Growth-Primed Adult Dorsal Root Ganglia Reveals Key Molecular Mediators for Peripheral Nerve Regeneration
por: Bautista, Maricris, et al.
Publicado: (2023)

The Many Faces of Neuroendocrine Differentiation in Prostate Cancer Progression
por: Terry, Stéphane, et al.
Publicado: (2014)

Molecular mechanisms of neuroendocrine differentiation in prostate cancer progression
por: Xie, Yuchen, et al.
Publicado: (2022)

Beta-adrenergic signaling on neuroendocrine differentiation, angiogenesis, and metastasis in prostate cancer progression
por: Zhao, Yicheng, et al.
Publicado: (2019)

Dependence on MUC1-C in Progression of Neuroendocrine Prostate Cancer
por: Kufe, Donald
Publicado: (2023)

Progress in Sympathetically Mediated Pathological Pain
por: Chen, Si-Si, et al.
Publicado: (2015)

Molecular Links Between Angiogenesis and Neuroendocrine Phenotypes in Prostate Cancer Progression
por: Wang, Zheng, et al.
Publicado: (2020)

APOBEC1 cytosine deaminase activity on single-stranded DNA is suppressed by replication protein A
por: Wong, Lai, et al.
Publicado: (2020)

Use of Nitrous Oxide to Facilitate Induction for Electroconvulsive Therapy: A Case Report
por: Lee, Kevin, et al.
Publicado: (2020)

Imaging of Neuroendocrine Prostatic Carcinoma
por: Taher, Ahmed, et al.
Publicado: (2021)

WLS-Wnt signaling promotes neuroendocrine prostate cancer
por: Bland, Tyler, et al.
Publicado: (2021)

A rare case of prostate neuroendocrine tumor: A case report
por: Teh, Shunxing, et al.
Publicado: (2022)

MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
por: Yasumizu, Yota, et al.
Publicado: (2020)

Global phosphoproteomic analysis identifies SRMS-regulated secondary signaling intermediates
por: Goel, Raghuveera Kumar, et al.
Publicado: (2018)

Neuroendocrine and sympathetic responses to an orexin receptor antagonist, SB-649868, and Alprazolam following insulin-induced hypoglycemia in humans
por: Patel, Ameera X., et al.
Publicado: (2014)

Nuclear iASPP may facilitate prostate cancer progression
por: Morris, E V, et al.
Publicado: (2014)

A Multipronged Unbiased Strategy Guides the Development of an Anti-EGFR/EPHA2–Bispecific Antibody for Combination Cancer Therapy
por: El Zawily, Amr, et al.
Publicado: (2023)

Neuroendocrine and Aggressive-Variant Prostate Cancer
por: Spetsieris, Nicholas, et al.
Publicado: (2020)

Deciphering the enigma of neuroendocrine prostate cancer
por: Karzai, Fatima, et al.
Publicado: (2022)

Clinicopathological and immunological profiles of prostate adenocarcinoma and neuroendocrine prostate cancer
por: Huang, Gang, et al.
Publicado: (2022)

Protein Tyrosine Kinases: Their Roles and Their Targeting in Leukemia
por: K. Bhanumathy, Kalpana, et al.
Publicado: (2021)

MAFG-AS1 is a prognostic biomarker and facilitates prostate cancer progression
por: Li, Peizhang, et al.
Publicado: (2022)

Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia With Progression to Neuroendocrine Tumor
por: Sousa, Débora, et al.
Publicado: (2021)

Lumbar Sympathetic Ganglion Block Facilitates Wound Healing in a Rat Ischemic Hindquarter Model
por: Shoji, Mami, et al.
Publicado: (2023)

Correlation of three immunohistochemically detected markers of neuroendocrine differentiation with clinical predictors of disease progression in prostate cancer
por: Ather, M Hammad, et al.
Publicado: (2008)

Germline Genetic Variation Modulates Tumor Progression and Metastasis in a Mouse Model of Neuroendocrine Prostate Carcinoma
por: Patel, Shashank J., et al.
Publicado: (2013)

Author Correction: MUC1-C regulates lineage plasticity driving progression to neuroendocrine prostate cancer
por: Yasumizu, Yota, et al.
Publicado: (2020)

Histone demethylase PHF8 drives neuroendocrine prostate cancer progression by epigenetically upregulating FOXA2
por: Liu, Qiuli, et al.
Publicado: (2020)

Molecular and Functional Links between Neurodevelopmental Processes and Treatment-Induced Neuroendocrine Plasticity in Prostate Cancer Progression
por: Kaarijärvi, Roosa, et al.
Publicado: (2021)

Prostate cancer with neuroendocrine differentiation – case report
por: Glück, G, et al.
Publicado: (2012)

Polycomb-mediated silencing in neuroendocrine prostate cancer
por: Clermont, Pier-Luc, et al.
Publicado: (2015)

Distribution of Neuroendocrine Cells in the Transition Zone of the Prostate
por: Kyoda, Yuki, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_cnf2b4ja57cdrfih734q0q7cv8